Announcing a new article publication for BIO Integration journal. Nitrofurantoin is a BCS II drug with a low solubility and dissolution rate. Therefore, the pharmaceutical applications of ...
Boehringer Ingelheim has struck a deal to apply Nanoform's nanoparticle technology to its preclinical pipeline prospects. The master services agreement positions the partners to work to improve the ...
Detailed price information for Cosmos Health Inc (COSM-Q) from The Globe and Mail including charting and trades.
RespireRx Pharmaceuticals Inc. RSPI in association with Jeffrey King managing attorney at Patent Networks Law Group, has filed a provisional patent application describing novel lipid-based formulation ...
Malaria remains a major global health burden, and the continued emergence of resistance to frontline therapies, including artemisinin-based combination ...
QUAKERTOWN, Pa.--(BUSINESS WIRE)--Microsize today announced the strategic investment and partnership with Helsinki-based The Solubility Company. Microsize's investment accelerates plans for The ...
These plots show powder X-ray diffraction measurements of three different types of formulations: simple mixing (a, d), the conventional evaporation/condensation ...
Paul Smaltz, Senior Vice President of BASF Pharma Solutions, explains how the company acts as a strategic partner to the ...
Cyclodextrins, a fascinating class of cyclic oligosaccharides, have garnered significant attention due to their unique ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results